• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨基酸变化导致血凝素对奥司他韦耐药的 H1N1 流感病毒的复制。

Amino acid changes in hemagglutinin contribute to the replication of oseltamivir-resistant H1N1 influenza viruses.

机构信息

Center for Infectious Diseases, Graduate School of Medicine, Kobe University, Kobe, Hyogo, Japan.

出版信息

J Virol. 2012 Jan;86(1):121-7. doi: 10.1128/JVI.06085-11. Epub 2011 Oct 19.

DOI:10.1128/JVI.06085-11
PMID:22013054
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3255889/
Abstract

Oseltamivir-resistant H1N1 influenza viruses emerged in 2007 to 2008 and have subsequently circulated widely. However, prior to 2007 to 2008, viruses possessing the neuraminidase (NA) H274Y mutation, which confers oseltamivir resistance, generally had low growth capability. NA mutations that compensate for the deleterious effect of the NA H274Y mutation have since been identified. Given the importance of the functional balance between hemagglutinin (HA) and NA, we focused on amino acid changes in HA. Reverse genetic analysis showed that a mutation at residue 82, 141, or 189 of the HA protein promotes virus replication in the presence of the NA H274Y mutation. Our findings thus identify HA mutations that contributed to the replacement of the oseltamivir-sensitive viruses of 2007 to 2008.

摘要

2007 年至 2008 年出现了对奥司他韦耐药的 H1N1 流感病毒,并随后广泛传播。然而,在 2007 年至 2008 年之前,具有神经氨酸酶(NA)H274Y 突变的病毒通常生长能力较低。此后,已鉴定出可补偿 NA H274Y 突变有害影响的 NA 突变。鉴于血凝素(HA)和 NA 之间功能平衡的重要性,我们专注于 HA 中的氨基酸变化。反向遗传分析表明,HA 蛋白残基 82、141 或 189 处的突变促进了在存在 NA H274Y 突变的情况下病毒的复制。因此,我们的研究结果确定了有助于取代 2007 年至 2008 年对奥司他韦敏感的病毒的 HA 突变。

相似文献

1
Amino acid changes in hemagglutinin contribute to the replication of oseltamivir-resistant H1N1 influenza viruses.氨基酸变化导致血凝素对奥司他韦耐药的 H1N1 流感病毒的复制。
J Virol. 2012 Jan;86(1):121-7. doi: 10.1128/JVI.06085-11. Epub 2011 Oct 19.
2
Molecular mechanism of the enhanced viral fitness contributed by secondary mutations in the hemagglutinin protein of oseltamivir resistant H1N1 influenza viruses: modeling studies of antibody and receptor binding.耐奥司他韦H1N1流感病毒血凝素蛋白中二次突变导致病毒适应性增强的分子机制:抗体与受体结合的建模研究
Gene. 2015 Feb 15;557(1):19-27. doi: 10.1016/j.gene.2014.12.003. Epub 2014 Dec 3.
3
Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.日本 2008-2009 年季节性流感期间出现 H274Y 耐药的奥司他韦抗甲型 H1N1 流感病毒。
J Clin Virol. 2010 Jan;47(1):23-8. doi: 10.1016/j.jcv.2009.11.003. Epub 2009 Dec 3.
4
Characteristics of oseltamivir-resistant influenza A (H1N1) pdm09 virus during the 2013-2014 influenza season in Mainland China.2013 - 2014年中国大陆流感季节期间甲型H1N1pdm09流感病毒对奥司他韦耐药的特征
Virol J. 2015 Jun 24;12:96. doi: 10.1186/s12985-015-0317-1.
5
Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A(H1N1) virus.与耐奥司他韦甲型H1N1流感病毒的医院内传播相关的发病率和死亡率。
JAMA. 2009 Mar 11;301(10):1042-6. doi: 10.1001/jama.2009.297. Epub 2009 Mar 2.
6
Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses.宿主细胞对流感神经氨酸酶变体的选择:对 A(H1N1)病毒药物耐药性监测的影响。
Antiviral Res. 2010 Feb;85(2):381-8. doi: 10.1016/j.antiviral.2009.11.005. Epub 2009 Nov 13.
7
Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011.2009-2011 年台湾地区奥司他韦耐药甲型 H1N1pdm09 流感病毒的特征。
J Med Virol. 2013 Mar;85(3):379-87. doi: 10.1002/jmv.23482. Epub 2012 Dec 21.
8
Genetic characterization of circulating seasonal Influenza A viruses (2005-2009) revealed introduction of oseltamivir resistant H1N1 strains during 2009 in eastern India.基因特征表明,2005 年至 2009 年期间,印度东部出现了对奥司他韦耐药的 H1N1 流感病毒。
Infect Genet Evol. 2010 Dec;10(8):1188-98. doi: 10.1016/j.meegid.2010.07.019. Epub 2010 Aug 1.
9
Pandemic H1N1 2009 influenza virus with the H275Y oseltamivir resistance neuraminidase mutation shows a small compromise in enzyme activity and viral fitness.具有 H275Y 奥司他韦耐药性神经氨酸酶突变的 2009 年大流行性 H1N1 流感病毒在酶活性和病毒适应性方面略有降低。
J Antimicrob Chemother. 2011 Mar;66(3):466-70. doi: 10.1093/jac/dkq486. Epub 2010 Dec 16.
10
Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors.重组抗流感神经氨酸酶抑制剂的甲型 H1N1 流感病毒的产生和鉴定。
J Infect Dis. 2011 Jan 1;203(1):25-31. doi: 10.1093/infdis/jiq010.

引用本文的文献

1
Natural variation in neuraminidase activity influences the evolutionary potential of the seasonal H1N1 lineage hemagglutinin.神经氨酸酶活性的自然变异影响季节性H1N1谱系血凝素的进化潜力。
Virus Evol. 2024 Jun 19;10(1):veae046. doi: 10.1093/ve/veae046. eCollection 2024.
2
Predicting Permissive Mutations That Improve the Fitness of A(H1N1)pdm09 Viruses Bearing the H275Y Neuraminidase Substitution.预测能够改善携带 H275Y 神经氨酸酶取代的 A(H1N1)pdm09 病毒适应性的许可性突变。
J Virol. 2022 Aug 10;96(15):e0091822. doi: 10.1128/jvi.00918-22. Epub 2022 Jul 14.
3
Mutation in Hemagglutinin Antigenic Sites in Influenza A pH1N1 Viruses from 2015-2019 in the United States Mountain West, Europe, and the Northern Hemisphere.2015-2019 年美国山区西部、欧洲和北半球流感 A pH1N1 病毒血凝素抗原位点的突变。
Genes (Basel). 2022 May 19;13(5):909. doi: 10.3390/genes13050909.
4
Quercetin as a Natural Therapeutic Candidate for the Treatment of Influenza Virus.槲皮素作为治疗流感病毒的天然治疗候选药物。
Biomolecules. 2020 Dec 24;11(1):10. doi: 10.3390/biom11010010.
5
Second sialic acid-binding site of influenza A virus neuraminidase: binding receptors for efficient release.流感 A 病毒神经氨酸酶的第二个唾液酸结合位点:结合受体以实现有效释放。
FEBS J. 2021 Oct;288(19):5598-5612. doi: 10.1111/febs.15668. Epub 2020 Dec 28.
6
Antivirals Targeting the Neuraminidase.抗神经氨酸酶药物。
Cold Spring Harb Perspect Med. 2022 Jan 4;12(1):a038455. doi: 10.1101/cshperspect.a038455.
7
A Single Amino Acid Substitution at Residue 218 of Hemagglutinin Improves the Growth of Influenza A(H7N9) Candidate Vaccine Viruses.一个位于血凝素 218 位的氨基酸单点替换提高了流感 A(H7N9)候选疫苗病毒的生长能力。
J Virol. 2019 Sep 12;93(19). doi: 10.1128/JVI.00570-19. Print 2019 Oct 1.
8
Mutations in Influenza A Virus Neuraminidase and Hemagglutinin Confer Resistance against a Broadly Neutralizing Hemagglutinin Stem Antibody.甲型流感病毒神经氨酸酶和血凝素的突变赋予了对广泛中和血凝素茎抗体的抗性。
J Virol. 2019 Jan 4;93(2). doi: 10.1128/JVI.01639-18. Print 2019 Jan 15.
9
Mutation and Epistasis in Influenza Virus Evolution.流感病毒进化中的突变和上位性作用。
Viruses. 2018 Aug 3;10(8):407. doi: 10.3390/v10080407.
10
The structural variability of the influenza A hemagglutinin receptor-binding site.流感 A 血凝素受体结合位点的结构变异性。
Brief Funct Genomics. 2018 Nov 26;17(6):415-427. doi: 10.1093/bfgp/elx042.

本文引用的文献

1
Permissive secondary mutations enable the evolution of influenza oseltamivir resistance.许可性次要突变使流感奥司他韦耐药性的进化成为可能。
Science. 2010 Jun 4;328(5983):1272-5. doi: 10.1126/science.1187816.
2
Glycosylation at 158N of the hemagglutinin protein and receptor binding specificity synergistically affect the antigenicity and immunogenicity of a live attenuated H5N1 A/Vietnam/1203/2004 vaccine virus in ferrets.血凝素蛋白158N位点的糖基化与受体结合特异性协同影响甲型H5N1流感病毒A/越南/1203/2004减毒活疫苗病毒在雪貂体内的抗原性和免疫原性。
J Virol. 2010 Jul;84(13):6570-7. doi: 10.1128/JVI.00221-10. Epub 2010 Apr 28.
3
TreeGraph 2: combining and visualizing evidence from different phylogenetic analyses.TreeGraph 2:整合和可视化来自不同系统发育分析的证据。
BMC Bioinformatics. 2010 Jan 5;11:7. doi: 10.1186/1471-2105-11-7.
4
Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.2007 - 2008年流感季节,欧洲出现对奥司他韦耐药的甲型流感病毒(H1N1)
Emerg Infect Dis. 2009 Apr;15(4):552-60. doi: 10.3201/eid1504.181280.
5
Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States.美国出现对奥司他韦耐药的甲型H1N1流感病毒感染情况。
JAMA. 2009 Mar 11;301(10):1034-41. doi: 10.1001/jama.2009.294. Epub 2009 Mar 2.
6
Use of oseltamivir in 12 European countries between 2002 and 2007--lack of association with the appearance of oseltamivir-resistant influenza A(H1N1) viruses.2002年至2007年间12个欧洲国家使用奥司他韦的情况——与奥司他韦耐药甲型H1N1流感病毒出现无关
Euro Surveill. 2009 Feb 5;14(5):19112. doi: 10.2807/ese.14.05.19112-en.
7
Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08.2007 - 2008年挪威出现的对奥司他韦耐药的甲型H1N1流感病毒
Emerg Infect Dis. 2009 Feb;15(2):155-62. doi: 10.3201/eid1502.081031.
8
Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir.季节性H1N1流感病毒神经氨酸酶的酶学特性为对奥司他韦产生天然抗性的出现提供了见解。
PLoS Pathog. 2008 Jul 25;4(7):e1000103. doi: 10.1371/journal.ppat.1000103.
9
The influenza virus resource at the National Center for Biotechnology Information.美国国立生物技术信息中心的流感病毒资源。
J Virol. 2008 Jan;82(2):596-601. doi: 10.1128/JVI.02005-07. Epub 2007 Oct 17.
10
Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificity.通过具有改变的受体结合特异性的禽H5流感血凝素突变体进行免疫接种。
Science. 2007 Aug 10;317(5839):825-8. doi: 10.1126/science.1135165.